• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用多杀性巴氏杆菌B:2的aroA基因减毒活疫苗免疫犊牛后,鉴定与预防出血性败血症相关的免疫原性蛋白。

Identification of immunogenic proteins associated with protection against haemorrhagic septicaemia after vaccination of calves with a live-attenuated aroA derivative of Pasteurella multocida B:2.

作者信息

Ataei Saeed, Burchmore Richard, Christopher Hodgson J, Finucane Anna, Parton Roger, Coote John G

机构信息

Division of Infection and Immunity, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow G12 8TA, United Kingdom.

出版信息

Res Vet Sci. 2009 Oct;87(2):207-10. doi: 10.1016/j.rvsc.2009.01.007. Epub 2009 Feb 24.

DOI:10.1016/j.rvsc.2009.01.007
PMID:19243798
Abstract

Pasteurella multocida serotype B:2 is the causative agent of haemorrhagic septicaemia (HS), a fatal disease of cattle and buffaloes. As a step towards the identification of individual antigens that may protect against HS, proteins present in a sonicated cell extract (SCE) and outer-membrane protein (OMP) preparation of a wild-type P. multocida serotype B:2 were investigated by immunoblotting with sera from calves which had been protected against challenge with a virulent strain of P. multocida B:2 by vaccination with a live-attenuated aroA derivative of the challenge strain. Five proteins in SCE, of approximately 50, 37, 30, 26 and 16 kDa, were recognised by the sera. In an OMP preparation, two bands, at 37 and 50 kDa, were recognised as strongly immunogenic. Mass spectrometry analysis of proteins corresponding in size to those detected by immunoblotting identified the 37 kDa band as OmpA, but the band at 50 kDa was not identified with certainty. A major 30 kDa OMP, identified as OmpH, was not strongly immunogenic.

摘要

多杀性巴氏杆菌B:2血清型是牛和水牛出血性败血症(HS)的病原体,这是一种致命疾病。作为鉴定可能预防HS的单个抗原的第一步,通过用来自已通过用强毒多杀性巴氏杆菌B:2的活减毒aroA衍生物进行疫苗接种而免受其攻击的小牛血清进行免疫印迹,研究了野生型多杀性巴氏杆菌B:2的超声破碎细胞提取物(SCE)和外膜蛋白(OMP)制剂中存在的蛋白质。SCE中的五种蛋白质,大小约为50、37、30、26和16 kDa,被血清识别。在OMP制剂中,37 kDa和50 kDa的两条带被认为具有强免疫原性。对与免疫印迹检测到的大小相对应的蛋白质进行质谱分析,确定37 kDa的条带为OmpA,但50 kDa的条带未确定。一种主要的30 kDa OMP,被鉴定为OmpH,没有强免疫原性。

相似文献

1
Identification of immunogenic proteins associated with protection against haemorrhagic septicaemia after vaccination of calves with a live-attenuated aroA derivative of Pasteurella multocida B:2.用多杀性巴氏杆菌B:2的aroA基因减毒活疫苗免疫犊牛后,鉴定与预防出血性败血症相关的免疫原性蛋白。
Res Vet Sci. 2009 Oct;87(2):207-10. doi: 10.1016/j.rvsc.2009.01.007. Epub 2009 Feb 24.
2
Cloning of 87 kDa outer membrane protein gene of Pasteurella multocida P52.多杀性巴氏杆菌P52 87 kDa外膜蛋白基因的克隆
Res Vet Sci. 2001 Jun;70(3):255-6. doi: 10.1053/rvsc.2001.0470.
3
Efficacy of vaccination of calves against hemorrhagic septicemia with a live aroA derivative of Pasteurella multocida B:2 by two different routes of administration.用多杀性巴氏杆菌B:2的aroA基因活衍生物通过两种不同给药途径对犊牛进行出血性败血症疫苗接种的效果。
Infect Immun. 2005 Mar;73(3):1475-81. doi: 10.1128/IAI.73.3.1475-1481.2005.
4
Safety and protective efficacy of intramuscular vaccination with a live aroA derivative of Pasteurella multocida B:2 against experimental hemorrhagic septicemia in calves.用多杀性巴氏杆菌B:2的aroA活衍生物进行肌肉注射疫苗接种对犊牛实验性出血性败血症的安全性和保护效果。
Infect Immun. 2007 Dec;75(12):5837-44. doi: 10.1128/IAI.00834-07. Epub 2007 Sep 17.
5
Prevention of haemorrhagic septicaemia in buffaloes and cattle with a live vaccine.使用活疫苗预防水牛和牛的出血性败血症
Vet Rec. 1989 May 13;124(19):508-9. doi: 10.1136/vr.124.19.508.
6
Prevention of experimental haemorrhagic septicaemia with a live vaccine.用活疫苗预防实验性出血性败血症
Vet Rec. 1987 May 23;120(21):500-1. doi: 10.1136/vr.120.21.500.
7
Developing a PmSLP3-based vaccine formulation that provides robust long-lasting protection against hemorrhagic septicemia-causing serogroup B and E strains of in cattle.研发基于 PmSLP3 的疫苗配方,为牛提供针对引起出血性败血病的 B 群和 E 群血清型菌株的强大、持久保护。
Front Immunol. 2024 May 21;15:1392681. doi: 10.3389/fimmu.2024.1392681. eCollection 2024.
8
Comparative analysis of the outer membrane protein profiles of isolates of the Pasteurella multocida (B:2) associated with haemorrhagic septicaemia.与出血性败血症相关的多杀性巴氏杆菌(B:2)分离株外膜蛋白谱的比较分析。
Vet Res Commun. 2002 Oct;26(7):513-22. doi: 10.1023/a:1020212430041.
9
Immunogenicity of outer membrane protein of Pasteurella multocida in buffalo calves.多杀性巴氏杆菌外膜蛋白在水牛犊牛中的免疫原性
Vet Microbiol. 1996 Oct;52(3-4):301-11. doi: 10.1016/s0378-1135(96)00066-1.
10
Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.用基于重组外膜蛋白H的出血性败血症疫苗对奶牛犊进行鼻内免疫接种。
J Vet Med Sci. 2018 Jan 27;80(1):68-76. doi: 10.1292/jvms.17-0176. Epub 2017 Nov 6.

引用本文的文献

1
Morphology, Biochemical, and Molecular Characterization of Causing Hemorrhagic Septicemia in Indonesia.印度尼西亚引起出血性败血症的病原菌的形态学、生化及分子特征
Vet Med Int. 2023 Mar 11;2023:7778707. doi: 10.1155/2023/7778707. eCollection 2023.
2
Spatial, Temporal, and Demographic Patterns in the Prevalence of Hemorrhagic Septicemia in 41 Countries in 2005-2019: A Systematic Analysis with Special Focus on the Potential Development of a New-Generation Vaccine.2005 - 2019年41个国家出血性败血症患病率的空间、时间和人口模式:一项特别关注新一代疫苗潜在研发的系统分析
Vaccines (Basel). 2022 Feb 17;10(2):315. doi: 10.3390/vaccines10020315.
3
Immune response in dairy cattle against combined foot and mouth disease and haemorrhagic septicemia vaccine under field conditions.
奶牛场条件下口蹄疫与出血性败血症二联疫苗的免疫反应。
BMC Vet Res. 2021 May 5;17(1):186. doi: 10.1186/s12917-021-02889-8.
4
Intranasal immunization with a recombinant outer membrane protein H based Haemorrhagic septicemia vaccine in dairy calves.用基于重组外膜蛋白H的出血性败血症疫苗对奶牛犊进行鼻内免疫接种。
J Vet Med Sci. 2018 Jan 27;80(1):68-76. doi: 10.1292/jvms.17-0176. Epub 2017 Nov 6.
5
Development of OMP based indirect ELISA to gauge the antibody titers in bovines against Pasteurella multocida.基于外膜蛋白(OMP)的间接酶联免疫吸附测定法的开发,用于测定牛针对多杀性巴氏杆菌的抗体效价。
Iran J Vet Res. 2015 Fall;16(4):350-6.
6
Outer membrane proteome analysis of Indian strain of Pasteurella multocida serotype B:2 by MALDI-TOF/MS analysis.通过基质辅助激光解吸电离飞行时间质谱(MALDI-TOF/MS)分析对多杀性巴氏杆菌B:2型印度菌株进行外膜蛋白质组分析。
ScientificWorldJournal. 2014;2014:617034. doi: 10.1155/2014/617034. Epub 2014 Dec 22.
7
Draft Genome Sequence of Pasteurella multocida subsp. multocida B:2 Strain VTCCBAA264 Isolated from Bubalus bubalis in North India.多杀性巴氏杆菌多杀亚种B:2菌株VTCCBAA264的基因组序列草图,该菌株从印度北部水牛中分离得到。
Genome Announc. 2014 Jul 31;2(4):e00755-14. doi: 10.1128/genomeA.00755-14.
8
Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles.多杀巴斯德氏菌和溶血曼海姆菌外膜囊泡的免疫原性。
Int J Med Microbiol. 2013 Jul;303(5):247-56. doi: 10.1016/j.ijmm.2013.05.001. Epub 2013 May 10.
9
Molecular heterogeneity of plpE gene in Indian isolates of Pasteurella multocida and expression of recombinant PlpE in vaccine strain of P. multocida serotype B: 2.印度多杀性巴氏杆菌分离株中plpE基因的分子异质性及重组PlpE在多杀性巴氏杆菌B:2血清型疫苗株中的表达:2
J Vet Sci. 2010 Sep;11(3):227-33. doi: 10.4142/jvs.2010.11.3.227.